A prospective controlled, randomized clinical trial of #kidney#transplant recipients developed personalized #tacrolimus dosing using model-based Bayesian Prediction
https://t.co/Ie5L0Pb1Gi
#rct@Nephrobellvitge
Gràcies Dr.@LluisLriera per la sessió d’avui que posa en valor tota una trajectòria dedicada al trasplantament renal. Mestre de molts uròlegs i uròlogues que s’han format a @hbellvitge. 😍
Descobreixen un microRNA que pot promoure el desenvolupament d’#aterosclerosi en pacients amb malaltia coronària
@idibell_cat@hbellvitge @IIBSantPau @ciberdem
Més informació ➡️ https://t.co/L42zNM9V9i
A comprehensive assessment of long-term SARS-CoV-2-specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients. 2022 from @Kidney_Int@OriolBestard
➡️ https://t.co/iyDVpVlrT1
El @hbellvitge es el centro que realizó más trasplantes renales en España en 2021. Además, junto con @hospitalclinic lideramos por primera vez la donación de vivo. No se puede tener un mejor equipo #Bellvitgenephrocrew https://t.co/UOD1M8hrs2
A reminder that, despite improved outcomes, mortality in SOT recipients with COVID-19 is still higher than in the general population @LVRiella@jazziup@UMaggiore:
Mortality in solid organ transplant recipients with COVID-19: more than meets the eye https://t.co/YI3beBdJtb
Avui fa 30 anys que @hbellvitge va fer el 1er trasplantament cardiac i ja portem mes de 500 procediments amb excel.lent supervivència. Moltes gracies a tots els profesionals, a la direcció i sobretot als donants i les seves families que ho han fet possible #orgullbellvitge
Sunday's Transplant Nephrology Series
By Dr. Leonardo V. Riella @LVRiella
Principles in Alloimmunity - Practical Aspects for the Non-transplant Nephrologist
Join https://t.co/i66NbaxloJ
Mtng ID: 937 9592 6539
Passcode 202122
sign up
https://t.co/foNIjuADki
Long-standing donor diabetes and pathologic findings are associated with shorter allograft survival in recipients of kidney transplants from diabetic donors | Modern Pathology #renalpath https://t.co/wa6geSenVk
KDIGO is pleased to share the 2021 Guideline for Glomerular Diseases and its Executive Summary: https://t.co/NxO5SaOjKZ.
We sincerely thank Guideline Co-Chairs, Dr. Brad Rovin and Dr. Jürgen Floege, and the Guideline Work Group, for their incredible work and dedication.
Excited to share our work by @BenIsraelow et al published today. We asked what are the roles of antibodies vs. T cells in controlling primary infection, reinfection, and vaccine-mediated protection? (1/n)
https://t.co/z79bUoYxhs
Felicitades @paugasol for your amazing career, thank you for all the battles and the memories, and for all the young kids from Europe like myself that you inspired 🙏🏽🙌🏽🇪🇸. #Legend
📢NEW in CKJ!
Management of posttransplant diabetes mellitus: an opportunity for novel therapeutics
📸Pathophysiology of PTDM
📸Summary of renal, cardiovascular & metabolic actions of GLP-1 RA, DPP4i & SLGLT2i
📖https://t.co/uhdVldStEV
@PepaSolerR@nuria_montero_p@crz_garrit
Post-Hoc analyses of ISCHEMIA-CKD study looking at patients listed for #kidney#transplant. Medical management vs invasive cardiac strategy in the setting of mod-severe ischemia and well-controlled or silent angina (left main excluded). Similar outcomes! https://t.co/6PY14k35LG